FDA Device Intelligence
HomeBERKELEY ADVANCED BIOMATERIALS, LLC › FBM-Osteo Foam Granules-Collagen Strip

FBM-Osteo Foam Granules-Collagen Strip

BERKELEY ADVANCED BIOMATERIALS, LLC · Model FBO2-50X10-02 · UDI-DI 00816125024902

MQV Prescription
1
510(k) clearances
2,073
Adverse events (45 deaths)
120
Recalls
225
Facilities

Description

FBM-Osteo Foam Granules-Collagen Strip is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone. FBM-Osteo Foam Granules-Collagen Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml.

Recalls

DateFirmReason
2026-07-02IsoTis OrthoBiologics, Inc.Demineralized bone matrix (DBM) in resorbable mesh indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis, were filled with approx. 4.5 cc
2026-03-25Orthorebirth Co LtdResorbable bone void filler falls outside standard specifications.
2026-03-25Orthorebirth Co LtdResorbable bone void filler falls outside standard specifications.
2026-03-09XTANT Medical Holdings, IncProducts were incorrectly labeled with a 5-year shelf life. The approved and validated shelf life is four years.
2025-09-02Berkeley Advanced Biomaterials, LLCDue to incorrect product label (Incorrect product name identified on outer packaging).
2025-04-07SCIENCE & BIO MATERIALSVials of implant bone granules may contain less product then specified on labeling.
2024-11-27IsoTis OrthoBiologics, Inc.Hydration issue resulting in the product being less cohesive and moldable than intended due to an issue with the polymer.
2024-11-27IsoTis OrthoBiologics, Inc.Incorrect expiration date listed on the outer box, which does not align with the correct expiration date listed on the inner tray.
2023-12-22Musculoskeletal Transplant Foundation, Inc.Filling process qualification did not demonstrate adequate process capability. Possible consequences include extended surgery time due to extrudability issues.
2023-12-22Musculoskeletal Transplant Foundation, Inc.Filling process qualification did not demonstrate adequate process capability. Possible consequences include extended surgery time due to extrudability issues.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.